Immunogenicity: Clinical Trials

5 trials for Immunogenicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 21Completed 1

Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30
Gonal F, jzb30 - Bioequivalence, Healthy Volunteers
Phase 1CompletedWest China Second University Hospital482021-01-042025-01-16
EMaBS TB Vaccine Study
ChAdOx185A, MVA85A, BCG - Safety, Immunogenicity
Phase 1 / Phase 2CompletedUniversity of Oxford722019-07-012022-08-05
Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
INTP5, US Neulasta - Immunogenicity, Healthy Volunteers
Phase 1CompletedIntas Pharmaceuticals, Ltd.2002018-02-262019-10-04
Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Shigella Sonnei O-SPC/rBRU - Immunogenicity, Shigellosis
Phase 1CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)602011-05-152019-12-16
Gardasil Vaccination in Post Stem Cell Transplant Patients
Gardasil - Gardasil Vaccine, Stem Cell Transplant
Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)642010-06-022019-08-06

Narrower conditions

Dysentery, Bacillary (1)  ·  Tuberculosis (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Infections (2)  ·  Actinomycetales Infections (1)  ·  Digestive System Diseases (1)  ·  Dysentery (1)  ·  Enterobacteriaceae Infections (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Intestinal Diseases (1)  ·  Mycobacterium Infections (1)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  MVA 85A (1)  ·  follitropin alfa (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Intas Pharmaceuticals, Ltd. (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  University of Oxford (1)  ·  West China Second University Hospital (1)

Countries

China (1)  ·  India (1)  ·  Israel (1)  ·  Uganda (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Adarsh K Garg, M.B.B.S (1)  ·  Feng-Ying C Lin, M.D. (1)  ·  Helen McShane, Professor (1)  ·  Qin Yu (1)  ·  Richard W Childs, M.D. (1)  ·  Vinu Jose, M.D. (1)

Results publications

PMID 32105293, PMID 41293254, PMID 42648772